Israeli startup New Phase is developing heat-activated iron-oxide nanoparticles that zero in on tumors and gently cook cancer cells from the inside, offering patients a promising, low-toxicity way to slow metastasis and extend life.

Beyond cognitive gains, many said the group format helped them feel understood and supported, providing emotional validation and a sense of community that eased the isolation often experienced after cancer treatment.

The findings suggests a possible new way to manage diabetes—by targeting the proteins that control nutrient flow rather than focusing only on insulin.

PROphet® uses a blood test to analyze thousands of plasma proteins and predict how patients are likely to respond to immunotherapy.

Crucially, the methods tested relied on technologies already approved for clinical use, meaning they could potentially reach patients in a relatively short time, the scientists said.

CAR-T therapy uses a patient’s own immune cells, genetically modified to fight cancer.

Unlike many existing treatments that rely on broad immune activation or genetic engineering, this approach focuses on making subtle internal changes that can be triggered not just genetically — but pharmacologically.

Cancer cells often evade detection by presenting very few identifiable markers. The Israeli researchers sought to change that.

While current treatments rely on surgery, radiation, and chemotherapy, this pioneering study suggests that precise gene-editing could offer a highly targeted and less invasive alternative.

The dual-drug delivery method demonstrated superior effectiveness compared to separate drug administration, even at doses 30 times lower than those used in prior studies.

These nanoparticles, capable of targeting and silencing negative regulators, restore NK cell activity directly within the patient’s body.

The research team analyzed how immune cells express genes when in proximity to cancerous tissue.

Newest service from Belong.Life provides automated solution for cancer clinical trial matching and recruitment.

An Israeli company has created a ground-breaking therapy based on nanoparticles to make cancer a chronic condition rather than a fatal one.

The discovery involves a chemical that can refocus the immune response in people with multiple myeloma, a blood malignancy that affects plasma cells that produce antibodies.

Israeli company Bilojic Design is joining the fight against cancer using artificial intelligence to design better medical treatments that can potentially revolutionize cancer treatment.

An Israeli diplomat is on a special mission to help bring Ukrainian children with cancer to Israel for treatment.

Natural killer cells are a potent defense weapon of the body that assists the immune system in its fight against viral infections, tumor growth and the spread of cancerous metastases.

Eliana Steinberg is the driving force behind a tiny chip that tests several treatments on the same tumor in record time, and she's only 28.

Israeli startup NeoTX may have cracked the code of how to trick the immune system into delivering a stronger response to tumors.

FDA-approved HemoScreen performs a complete blood count test in just five minutes.

Prof. Yoram Palti’s 'accomplishments are a source of great pride to the State of Israel and an inspiration for the young generation.'

"Our new chip is like an artificial cancer, that can be put in a petri dish."

The revolutionary Israeli treatment avoids surgery by using liquid nitrogen to freeze cancerous tumors.

This innovative anti-cancer treatment provides new hope to patients with multiple myeloma, a common form of blood cancer.

A team at Israel’s Hebrew University made one of the most important leukemia research breakthroughs in 40 years, putting a cure for the disease within reach for the first time ever.

Israeli scientists may have found a way to treat cancer-once and for all. No more relapses-just a healthier, happier tomorrow!

A revolutionary cancer treatment is about to change the world - thanks to Israel!

A Weizmann Institute scientist developed a cancer immunotherapy compound that is 30 times more effective than existing treatments, and much more.

“The FDA approval of Yescarta is a landmark for patients with relapsed or refractory large B-cell lymphom."

The world authority on Jewish mysticism explained the meaning behind the 'mezuzah' and bestowed his blessing on a company specializing in precision cancer medicine.

IDF cadets developed a digital bracelet to attach to injured soldiers; VBL Therapeutics develops treatment to fight tumors; Zebra Medical Vision has launched fast, accurate medical image analysis over the web, and much more.

Israeli startup Parasonic has developed a comb device that destroys lice and lice eggs with ultrasound waves; Tiny barcodes record the effectiveness of cancer treatments, and much more.

With this groundbreaking device, a doctor can quickly and easily identify the cancer and begin treatment immediately.

Researchers at the Technion in Israel have come up with an individualized treatment for different cancer patients.